✦ LIBER ✦

A Differential T-Helper 17 Immune Response in Responders to Antiviral Therapy for Chronic Hepatitis C

✍ Scribed by Seetharam, Anil B. ;Subramanian, Vijay ;Angaswamy, Nataraju ;Tiriveedhi, Venkataswarup ;Korenblat, Kevin M. ;Lisker-Melman, Mauricio ;Crippin, Jeffrey ;Mohanakumar, T.

Book ID: 122138273
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 719 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63923-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to triple antiviral therapy in

Response to triple antiviral therapy in interferon non-responders with chronic hepatitis C

✍ S. Brillanti; M. Foli; M. Di Tomaso; L. Gramantieri; C. Masci; L. Bolondi 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Racial differences in the response to an

Racial differences in the response to antiviral therapy for chronic hepatitis C

✍ A. Colantoni; N. De Maria; R. Idilman; J. Harig; D.H. Van Thiel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

T-cell response relative to genotype and

T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C

✍ David E. Kaplan; Kazushi Sugimoto; Fusao Ikeda; Jason Stadanlick; Mary Valiga; K 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

Viral genotype and host ethnicity are important predictors of viral clearance during antiviral therapy for chronic hepatitis C virus (HCV) infection. Based on the role of T cells in natural HCV clearance, we hypothesized that T cells may contribute to the genotypic and ethnic difference in treatment

63 SILIBININ IS A POTENT ANTIVIRAL AGENT

63 SILIBININ IS A POTENT ANTIVIRAL AGENT IN PATIENTS WITH CHRONIC HEPATITIS C NOT RESPONDING TO ANTIVIRAL COMBINATION THERAPY

✍ P. Ferenci; T.M. Scherzer; H. Hofer; M. Sch¨oniger-Hekele; P. Steindl-Munda 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Hepatocellular carcinoma in long-term su

Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C

✍ T.-M. Scherzer; K. R. Reddy; F. Wrba; H. Hofer; K. Staufer; P. Steindl-Munda; A. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

T.N.17 DIFFERENTIAL EFFECTS OF PEGYLATED

T.N.17 DIFFERENTIAL EFFECTS OF PEGYLATED INTERFERON ALPHA THERAPY ON INNATE AND ADAPTIVE IMMUNE RESPONSES IN CHRONIC HEPATITIS B

✍ L. Micco; D. Peppa; E. Loggi; C. Cursaro; F. Bihl; M. Bernardi; P. Andreone; M.K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB